A call to action from a CEO on the front lines of the opioid crisis

Richard F. Pops
CEO of Alkermes since 1991

My company, Alkermes, has been at work since the late 1990s developing and bringing to patients a medicine that helps them fight addiction to opioids. As we set out on that path, CEOs of larger companies urged me to reconsider that decision. They pointed out that addiction is a difficult disease with challenging patients, a […]

Read more